 |
|
 |
 |

Home > Company Index > Health Products & Services > Medical Laboratories & Research > Covance Inc.
 |
Covance Inc. |
 |
 |
 |
NEWS FROM THE WIRES |
 |
Small-cap stocks: Healthcare favored on earnings strength Jul 31 2001 09:43 AM PDT
Covance says profits rise, after charges Jul 25 2001 02:05 PM PDT
> More WIRE STORIES about this company
PROFILE |
 |
Covance is killer when it comes to contract research. The contract research organization (CRO) develops and carries out preclinical and clinical trials of potential commercial drugs. Covance offers health economics and laboratory testing; it will also assist a company in moving a drug through the regulatory approval process. Other services include manufacturing as well as data management and analysis. Covance serves such customers as pharmaceutical companies, hospitals, managed care organizations, and laboratory testing services in the chemical, agrochemical, and food industries. Covance has operations in 17 countries around the world.
COMPETITION |
 |
PAREXEL International Corporation (PRXL)
Pharmaceutical Product Development, Inc. (PPDI)
Quintiles Transnational Corp. (QTRN)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 868.10
1-Yr. Sales Growth: 4.7%
Employees: 7,900
Revenue per employee: $109,886.08
KEY PEOPLE |
 |
Christopher A. Kuebler
CEO
Charles C. Harwood
CFO
CONTACT INFO |
 |
210 Carnegie Center
Princeton, NJ 08540
US
Phone: 609-452-4440
Fax: 609-452-9375
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |